# Stratified Medicine of Eplerenone in Acute Myocardial Infarction or Injury and no Obstructive Coronary Arteries.

> **NCT05198791** · PHASE2 · RECRUITING · sponsor: **NHS National Waiting Times Centre Board** · enrollment: 400 (estimated)

## Conditions studied

- Myocardial Infarction, Acute
- Myocardial Infarction With Nonobstructive Coronary Arteries
- Myocardial Injury

## Interventions

- **DRUG:** Stratified medicine - Microvascular dysfunction and eplerenone therapy, tablets
- **OTHER:** Stratification and standard care

## Key facts

- **NCT ID:** NCT05198791
- **Lead sponsor:** NHS National Waiting Times Centre Board
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-02-04
- **Primary completion:** 2026-07-31
- **Final completion:** 2026-07-31
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2026-03-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05198791

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05198791, "Stratified Medicine of Eplerenone in Acute Myocardial Infarction or Injury and no Obstructive Coronary Arteries.". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05198791. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*